Celecoxib decreases prostaglandin E<sub>2 </sub>concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer
<p>Abstract</p> <p>Background</p> <p>Celecoxib inhibits PGE2 production in cancerous tissue. We previously reported that PGE2 levels in nipple aspirate fluid (NAF) and plasma were not decreased in women at increased breast cancer risk who received celecoxib 200 mg twice...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2006-10-01
|
| Series: | BMC Cancer |
| Online Access: | http://www.biomedcentral.com/1471-2407/6/248 |